Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence

Ted Smith, Rochelle H Holm, Rachel J Keith, Alok R Amraotkar, Chance R Alvarado, Krzysztof Banecki, Boseung Choi, Ian C Santisteban, Adrienne M Bushau-Sprinkle, Kathleen T Kitterman, Joshua Fuqua, Krystal T Hamorsky, Kenneth E Palmer, J Michael Brick, Grzegorz A Rempala, Aruni Bhatnagar
doi: https://doi.org/10.1101/2022.04.28.22274086
Ted Smith
1Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rochelle H Holm
1Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel J Keith
1Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alok R Amraotkar
1Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY 40202, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chance R Alvarado
2Division of Epidemiology, College of Public Health, The Ohio State University, Columbus OH 43210, USA
MMS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krzysztof Banecki
3Department of Mathematics and Information Science, Warsaw University of Technology, Warsaw Pl. Politechniki 1, Poland
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boseung Choi
4Division of Big Data Science, Korea University, Sejong, South Korea/Biomedical Mathematics Group, Institute for Basic Science, Daejeon, South Korea
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian C Santisteban
5Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne M Bushau-Sprinkle
5Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
6Department of Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen T Kitterman
5Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua Fuqua
5Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
7Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krystal T Hamorsky
5Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
6Department of Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth E Palmer
5Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
7Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Michael Brick
8Westat, Inc., Rockville, MD 20850, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grzegorz A Rempala
9Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH 43210, USA
DSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aruni Bhatnagar
1Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY 40202, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aruni.bhatnagar@louisville.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Wastewater-based epidemiology is a promising approach but robust epidemiological models to relate wastewater to community prevalence are lacking. Assessments of SARS-CoV-2 infection rates have relied primarily on convenience sampling, which does not provide reliable estimates of community prevalence because of inherent biases.

Methods From August 2020 to February 2021, we conducted a serial stratified randomized samplings to estimate the prevalence of anti-SARS-CoV-2 antibodies in 3,717 participants, and weekly sampling of community wastewater for SARS-CoV-2 concentrations in Jefferson County, KY. With the use of a Susceptible, Infected, Recovered (SIR)-type model, we obtained longitudinal estimates of prevalence and compared these with wastewater concentration, using regression analysis.

Findings Model analysis revealed significant temporal differences in epidemic peaks; the average incidence rate based on serological sampling in some areas was up to 50% higher than health department rates based on convenience sampling. The model-estimated average prevalence rates correlated well with wastewater (correlation=0·63). In regression analysis, a weekly unit increase in wastewater concentration of SARS-CoV-2 corresponded to an average increase of between 1-1·3 cases of SARS-CoV-2 infection per 100K residents.

Interpretation Publicly available health department incidence rates vastly underestimate true community incidence and wastewater has a high potential to provide robust estimates of community spread of infection.

Evidence before this study Administratively reported clinical case rates of coronavirus disease 2019 (COVID-19) infected individuals are biased due to a wide range of factors from testing access to concerns about missing low and non-symptomatic and self-tested individuals. Wastewater estimates offer an alternative to support community monitoring based on fecal shedding of the virus but are difficult to interpret when compared with the available public health data sets of infection rates. We examined all English literature until February 24, 2022, on Web of Science and PubMed with the terms [“seroprevalence” or “antibody”] AND [“COVID-19” or “SARS-CoV-2”] AND [“wastewater”]. We identified six studies. None of these studies considered randomized COVID-19 community anti-SARS-CoV-2 antibody testing paired with wastewater data.

Added value of this study The study demonstrates how results from serial stratified randomized serological sampling of the community can be used to build a longitudinal model that can interpolate and extrapolate community levels of infection beyond specific testing dates. Such a model correlates well with wastewater concentrations indicating its utility as a surrogate for infection prevalence. The testing data used in the study were collected before wide availability of COVID-19 vaccines and are therefore unique as they are unlikely to include a significant number of false positive results.

Implications of all the available evidence The study demonstrates that convenience sampling obtained data from health department reporting seriously underestimates community-wide prevalence of infection. In contrast, wastewater-based epidemiology may be a faster, cost-effective, and more robust method of estimating the prevalence of viral infections within specific urban areas.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a contract by the Centers for Disease Control, the Louisville-Jefferson County Metro Government as a component of the Coronavirus Aid, Relief, and Economic Security Act, as well as grants from the James Graham Brown Foundation and the Owsley Brown II Family Foundation. Serology work was also supported in part by the Jewish Heritage Fund and the Center for Predictive Medicine for Biodefense and Emerging Infectious Disease.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

For the seroprevalence and data on COVID-19 infected individuals provided by the LMPHW under a Data Transfer Agreement, the University of Louisville Institutional Review Board approved this as Human Subjects Research (IRB number: 20.0393). For the wastewater, the University of Louisville Institutional Review Board classified this as non-human subjects research (reference #: 717950).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Joint first authors

Data Availability

The seroprevalence and wastewater data used in the study can be accessed at https://github.com/cbskust/Seroprevalene.COVID19. The computer code implementing our model-based analysis will be made available immediately following publication. The code will be shared with researchers who provide a methodologically sound proposal approved by GAR and AB. Proposals should be directed to rempala.3{at}osu.edu and aruni.bhatnagar{at}louisville.edu; requesters will need to sign a data access agreement.

https://github.com/cbskust/Seroprevalene.COVID19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 01, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence
Ted Smith, Rochelle H Holm, Rachel J Keith, Alok R Amraotkar, Chance R Alvarado, Krzysztof Banecki, Boseung Choi, Ian C Santisteban, Adrienne M Bushau-Sprinkle, Kathleen T Kitterman, Joshua Fuqua, Krystal T Hamorsky, Kenneth E Palmer, J Michael Brick, Grzegorz A Rempala, Aruni Bhatnagar
medRxiv 2022.04.28.22274086; doi: https://doi.org/10.1101/2022.04.28.22274086
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence
Ted Smith, Rochelle H Holm, Rachel J Keith, Alok R Amraotkar, Chance R Alvarado, Krzysztof Banecki, Boseung Choi, Ian C Santisteban, Adrienne M Bushau-Sprinkle, Kathleen T Kitterman, Joshua Fuqua, Krystal T Hamorsky, Kenneth E Palmer, J Michael Brick, Grzegorz A Rempala, Aruni Bhatnagar
medRxiv 2022.04.28.22274086; doi: https://doi.org/10.1101/2022.04.28.22274086

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (313)
  • Allergy and Immunology (617)
  • Anesthesia (158)
  • Cardiovascular Medicine (2264)
  • Dentistry and Oral Medicine (279)
  • Dermatology (201)
  • Emergency Medicine (369)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (797)
  • Epidemiology (11554)
  • Forensic Medicine (10)
  • Gastroenterology (676)
  • Genetic and Genomic Medicine (3551)
  • Geriatric Medicine (336)
  • Health Economics (614)
  • Health Informatics (2289)
  • Health Policy (911)
  • Health Systems and Quality Improvement (859)
  • Hematology (333)
  • HIV/AIDS (745)
  • Infectious Diseases (except HIV/AIDS) (13131)
  • Intensive Care and Critical Care Medicine (755)
  • Medical Education (357)
  • Medical Ethics (100)
  • Nephrology (387)
  • Neurology (3337)
  • Nursing (191)
  • Nutrition (505)
  • Obstetrics and Gynecology (649)
  • Occupational and Environmental Health (643)
  • Oncology (1750)
  • Ophthalmology (524)
  • Orthopedics (208)
  • Otolaryngology (284)
  • Pain Medicine (223)
  • Palliative Medicine (66)
  • Pathology (437)
  • Pediatrics (998)
  • Pharmacology and Therapeutics (418)
  • Primary Care Research (400)
  • Psychiatry and Clinical Psychology (3046)
  • Public and Global Health (5978)
  • Radiology and Imaging (1217)
  • Rehabilitation Medicine and Physical Therapy (712)
  • Respiratory Medicine (808)
  • Rheumatology (367)
  • Sexual and Reproductive Health (346)
  • Sports Medicine (312)
  • Surgery (383)
  • Toxicology (50)
  • Transplantation (170)
  • Urology (142)